Conversion from Twice-Daily Prograf® to Once-Daily Advagraf® in Multi-ethnic Asian Adult Renal Transplant Recipients With or Without Concomitant Use of Diltiazem: Impact of CYP3A5 and MDR1 Genetic Polymorphisms on Tacrolimus Exposure

被引：0

作者：

Wai-Ping Yau

Charlene Wei-Ting Loh

Anantharaman Vathsala

机构：

[1] National University of Singapore,Department of Pharmacy, Faculty of Science

[2] National University Hospital,National University Centre for Organ Transplantation

[3] National University of Singapore,Department of Medicine, Yong Loo Lin School of Medicine

来源：

European Journal of Drug Metabolism and Pharmacokinetics | 2019年 / 44卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：481 / 492

页数：11

共 25 条

[21] Influence of Cytochrome P450 3A5 (CYP3A5) Genetic Polymorphism on the Pharmacokinetics of the Prolonged-Release, Once-Daily Formulation of Tacrolimus in Stable Renal Transplant Recipients
François Glowacki
Arnaud Lionet
Jean-Philippe Hammelin
Myriam Labalette
François Provôt
Marc Hazzan
Franck Broly
Christian Noël
Christelle Cauffiez
Clinical Pharmacokinetics, 2011, 50 : 451 - 459
[22] Influence of Cytochrome P450 3A5 (CYP3A5) Genetic Polymorphism on the Pharmacokinetics of the Prolonged-Release, Once-Daily Formulation of Tacrolimus in Stable Renal Transplant Recipients
Glowacki, Francois
Lionet, Arnaud
Hammelin, Jean-Philippe
Labalette, Myriam
Provot, Francois
Hazzan, Marc
Broly, Franck
Noel, Christian
Cauffiez, Christelle
CLINICAL PHARMACOKINETICS, 2011, 50 (07) : 451 - 459
[23] SCOTTISH RENAL TRANSPLANT PATIENTS CONVERTED TO ONCE-DAILY TACROLIMUS AND THE INFLUENCE OF GENETIC POLYMORPHISMS OF CYP3A5, CY3A4*22 AND ABCB1 ON DOSE, TROUGH LEVELS AND CLINICAL OUTCOMES
Falconer, Stuart
Cryer, Claire
Turner, David
Oniscu, Gabriel
TRANSPLANT INTERNATIONAL, 2015, 28 : 757 - 757
[24] Higher Initial Exposure of Envarsus Immediately Post Transplantation Is Not Associated With Increased Risk of Delayed Graft Function in Kidney Transplant Patients Treated With Novel Once-Daily MeltDose Tacrolimus (Envarsus) Vs. Twice-Daily Tacrolimus (Prograf): Results From a Phase 3, Double-Blind, Double-Dummy, Multi-Center, Randomized Trial
Budde, K.
Silva, H.
Steinberg, S.
Kamar, N.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 460 - 460
[25] Higher Initial Exposure of Envarsus Immediately Post Transplantation Is Not Associated With Increased Risk of Delayed Graft Function in Kidney Transplant Patients Treated With Novel Once-Daily MeltDose Tacrolimus (Envarsus) Vs. Twice-Daily Tacrolimus (Prograf): Results From a Phase 3, Double-Blind, Double-Dummy, Multi-Center, Randomized Trial
Budde, K.
Silva, H.
Steinberg, S.
Kamar, N.
TRANSPLANTATION, 2014, 98 : 460 - 460

← 1 2 3 →